Seattle Genetics

Seattle Genetics, Inc. is a clinical-stage biotechnology company developing monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. The Company has a worldwide collaboration agreement with Genentech, Inc. to develop and commercialize the product candidate SGN-40. It also has two other product candidates in clinical trials, SGN-33 and SGN-35, and several lead preclinical product candidates including SGN-70, SGN-75 and an anti-CD19 antibody-drug conjugate (ADC). In addition to its internal pipeline, the Company has ADC license agreements with a number of biotechnology ...


Scholarships

There are no scholarships at this time

 Events

There are no events at this time

Company Data on Seattle Genetics
provided by Owler


 

Seattle Genetics is hiring for these positions

Show me: All available jobs
loading